Want to see MKL full AI Analyst Report?
Top Page
Markel
(NYSE:MKL)
Select Model
Select Model
Rating:75Outperform
Price Target:
$2,267.00
▲(13.65% Upside)
Action:Reiterated
Date:07/30/26
The score is driven primarily by strong underlying financial quality (conservative leverage, solid profitability, and strong cash conversion) and supportive price trend versus major moving averages. Earnings call commentary adds a positive tilt (double-digit ROE pacing and improved underwriting), partially offset by the State National charge and softer adjusted operating income. Valuation is reasonable on P/E, but the lack of dividend yield data limits further support.
Positive Factors
Conservative leverage & strong equity base
A low debt-to-equity ratio and materially higher equity provide durable balance-sheet resilience through underwriting and investment cycles. That capital base supports capacity to write specialty business, absorb reserve volatility, maintain ratings, and fund strategic deployments without overreliance on external funding.
Negative Factors
State National $205M reserve
A material credit-related reserve is a structural red flag for counterparty/capacity-provider exposure. The $205M charge reduced Financial segment results and highlights the need for ongoing credit oversight; similar counterparty issues could meaningfully affect earnings and capital going forward.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative leverage & strong equity base
A low debt-to-equity ratio and materially higher equity provide durable balance-sheet resilience through underwriting and investment cycles. That capital base supports capacity to write specialty business, absorb reserve volatility, maintain ratings, and fund strategic deployments without overreliance on external funding.
Read all positive factors
Markel (MKL) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$23.32B
Dividend YieldN/A
Average Volume (3M)68.13K
Price to Earnings (P/E)10.3
Beta (1Y)0.58
Revenue Growth0.86%
EPS Growth8.75%
CountryUS
Employees22,900
SectorFinancial
Sector Strength70
IndustryInsurance - Property & Casualty
Share Statistics
EPS (TTM)182.57
Shares Outstanding12,389,958
10 Day Avg. Volume52,624
30 Day Avg. Volume68,126
Financial Highlights & Ratios
PEG Ratio-0.84
Price to Book (P/B)1.47
Price to Sales (P/S)1.65
P/FCF Ratio10.69
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$1,950.00Price Target Upside-2.24% Downside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)103.17
Revenue Forecast (FY)$14.85B
Markel Business Overview & Revenue Model
Company Description
Markel Corporation operates as a multifaceted financial conglomerate, engaging in the marketing and underwriting of specialized insurance offerings across numerous global regions. Its operational footprint spans the United States, Bermuda, the Uni...
How the Company Makes Money
Markel primarily makes money through a combination of (1) insurance underwriting results, (2) investment income and gains generated from investing insurance float and holding-company capital, and (3) earnings from its non-insurance operating busin...
Markel Earnings Call Summary
Earnings Call Date:Jul 29, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 04, 2026
Earnings Call Sentiment Positive
The call presents a generally positive overall picture driven by strong GAAP operating income (helped by volatile net investment gains), higher net income per share, improved insurance combined ratios and international growth, meaningful share repurchases funded from earnings, and material operational progress (AI initiatives). The most significant negatives are the $205M State National reserve/charge that produced material losses in the Financial segment, a decline in adjusted operating income (ex-investments) versus prior year, softer underwriting GWP and margin pressure in Industrial. Management communicated confidence in capital strength and conservatism in reserving and emphasized long-term progress, suggesting the positives outweigh the negatives.Positive Updates
Strong GAAP Operating Income and Net Income
Operating income (including net investment gains) was $1.6B for Q2 2026 vs $1.1B in Q2 2025. Net income to common shareholders was $1.2B ($93 per diluted share) for the quarter vs $631M ($50 per diluted share) a year ago.
Negative Updates
State National Collateral Shortfall and $205M Reserve
Recognized a $205M reserve related to a collateral shortfall tied to a particular capacity provider in bankruptcy at State National (first substantial credit loss in State National's >40-year history). Management described the estimate as conservative.
Read all updates
Q2-2026 Updates
Positive
Negative
Strong GAAP Operating Income and Net Income
Operating income (including net investment gains) was $1.6B for Q2 2026 vs $1.1B in Q2 2025. Net income to common shareholders was $1.2B ($93 per diluted share) for the quarter vs $631M ($50 per diluted share) a year ago.
Read all positive updates
Company Guidance
Management reiterated a multi‑year (5‑year) focus while saying the company is “on pace” for double‑digit return on equity for 2026 and highlighted numerous near‑term metrics: consolidated operating revenues of $4.0B in Q2 ($7.6B YTD), operating income of $1.6B in Q2, adjusted operating income of $436M in Q2 ($934M YTD), net income to common of $1.2B or $93 per diluted share in Q2 ($957M or $74 YTD), Markel Insurance underwriting GWP of $2.4B in Q2 (GWP down to $4.6B YTD but +10% ex‑Global Re/Hagerty), a combined ratio of 93% (93% H1), insurance adjusted operating income $376M in Q2 ($746M H1) and total insurance operating income of $1.2B for H1 (putting the company on pace for double‑digit ROE), net investment income of $256M in Q2 ($512M H1), public equities fair value $13.5B (up 10% QoQ; cumulative pretax unrealized gain $9.3B), a $205M collateral shortfall reserve at State National recognized in Q2, share repurchases of $237M in the quarter ($371M YTD, >$2B since 2022) reducing shares from 13.7M to 12.4M (~10%), and longer‑term five‑year averages of $2.5B annual operating income and $188.94 operating income per share (CAGRs ~15–16%); management also discussed reserve releases in workers’ comp and first‑party lines and said last quarter’s cited $700M underwriting profit target may be “a little lighter,” while favorable reserve development of up to ~5% (≈$800M) for 2026 was discussed but not definitively reconfirmed.Markel Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
82
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.35B | 16.59B | 16.75B | 15.71B | 11.81B | 12.92B |
| Gross Profit | 10.80B | 11.51B | 9.27B | 8.08B | 3.41B | 5.89B |
| EBITDA | 3.28B | 3.29B | 4.18B | 3.16B | 353.94M | 3.65B |
| Net Income | 2.28B | 2.11B | 2.75B | 2.00B | -216.28M | 2.42B |
Balance Sheet | ||||||
| Total Assets | 71.26B | 68.91B | 47.35B | 43.44B | 49.79B | 48.48B |
| Cash, Cash Equivalents and Short-Term Investments | 5.76B | 11.03B | 4.19B | 4.33B | 18.66B | 18.37B |
| Total Debt | 4.37B | 4.30B | 5.65B | 4.97B | 4.10B | 4.82B |
| Total Liabilities | 52.26B | 49.80B | 29.88B | 27.92B | 36.05B | 33.28B |
| Stockholders Equity | 19.01B | 18.60B | 16.92B | 14.98B | 13.15B | 14.72B |
Cash Flow | ||||||
| Free Cash Flow | 2.12B | 2.55B | 2.34B | 2.53B | 2.45B | 2.13B |
| Operating Cash Flow | 2.33B | 2.76B | 2.59B | 2.79B | 2.71B | 2.27B |
| Investing Cash Flow | -1.88B | -1.19B | -2.40B | -2.70B | -1.67B | -2.94B |
| Financing Cash Flow | -642.36M | -1.21B | -297.88M | -999.72M | -595.31M | 369.77M |
Markel Technical Analysis
Negative
1994.70
Price Trends
1900.20
Negative
1894.14
Negative
1974.24
Negative
Market Momentum
-0.08
Positive
42.01
Neutral
12.23
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MKL, the sentiment is Negative. The current price of 1994.7 is above the 20-day moving average (MA) of 1953.24, above the 50-day MA of 1900.20, and above the 200-day MA of 1974.24, indicating a bearish trend. The MACD of -0.08 indicates Positive momentum. The RSI at 42.01 is Neutral, neither overbought nor oversold. The STOCH value of 12.23 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MKL.
Markel Risk Analysis
Markel disclosed 21 risk factors in its most recent earnings report. Markel reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Markel Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $27.27B | 8.35 | 20.89% | 1.98% | 19.55% | 84.05% | |
78 Outperform | $11.77B | 13.48 | 18.76% | 4.88% | -1.65% | 10.67% | |
78 Outperform | $27.00B | 14.83 | 19.55% | 2.44% | 4.27% | 10.55% | |
75 Outperform | $23.32B | 10.31 | 16.09% | ― | 0.86% | 8.75% | |
74 Outperform | $14.19B | 11.71 | 11.99% | 7.23% | 4.05% | 35.90% | |
73 Outperform | $23.87B | 14.74 | 10.21% | 0.21% | 4.17% | 29.30% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
* Financial Sector Average
MKL
Markel
1,887.65
-50.93
-2.63%
AFG
American Financial Group
140.60
22.56
19.11%
CINF
Cincinnati Financial
179.42
32.29
21.94%
CNA
CNA Financial
52.96
10.03
23.37%
L
Loews
115.98
22.90
24.61%
WRB
W. R. Berkley Corporation
71.39
3.22
4.72%
Markel Corporate Events
Executive/Board ChangesShareholder Meetings
Markel shareholders reaffirm board, pay practices and auditor
Neutral
May 22, 2026
At its 2026 annual meeting, Markel shareholders elected the full slate of directors to serve until the 2027 meeting and approved, on an advisory basis, compensation for the company’s named executive officers. Investors also ratified KPMG LLP...
Business Operations and StrategyFinancial DisclosuresShareholder Meetings
Markel Highlights Growth, Capital Returns at Annual Meeting
Positive
May 20, 2026
On May 20, 2026, Markel Group’s leadership presented to shareholders at the company’s annual meeting, highlighting substantial growth in operating revenues, adjusted operating income, and earned premiums between the 2011–2015, 20...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.